What is the market cap of Dr Fresh Assets Limited?

Based on available unlisted market data, Dr Fresh Assets Limited had a market capitalization of approximately ₹48.69 Cr at a share price of around ₹45. The company's book value per share is ₹46.92, and it trades at a price-to-book ratio of approximately 0.96x.

Is Dr Fresh Assets Limited profitable?

Dr Fresh Assets Limited reports an EPS of ₹0.75 at a face value of ₹10, suggesting positive but modest profitability. Detailed revenue and PAT figures are not publicly disclosed.

Is Dr Fresh Assets Limited planning an IPO?

No IPO announcement has been made by Dr Fresh Assets Limited as of mid-2025.

How do I buy Dr Fresh Assets unlisted shares here?

Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Dr Fresh Assets?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Dr Fresh Assets shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Dr Fresh Assets Unlisted Share Price | Buy Dr Fresh Assets Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Dr Fresh Assets Unlisted Share Price | Buy Dr Fresh Assets Pre-IPO Shares — wisefolio | wisefolio

Investment Thesis

Dr Fresh Assets Limited is a small-cap diversified unlisted company based in New Delhi, operating in real estate, lifestyle, and healthcare. With a market cap of ~₹48.69 Cr and a P/BV of ~0.96x, it trades near book value, but the very limited revenue scale and absence of public disclosures make it a high-risk, low-visibility investment proposition.

Pros

Market capitalization of approximately ₹48.69 Cr at a price-to-book value of 0.96x, suggesting the stock trades near book value — a potential indicator of undervaluation.
Diversified business model spanning real estate, lifestyle, and healthcare segments provides revenue diversification.
Listed (unlisted public) company incorporated in 1990 with over three decades of operational history, providing institutional stability.
EPS of ₹0.75 reported with a face value of ₹10 per share, indicating the company has a positive earnings base.

Cons

Very small market capitalization of ~₹48.69 Cr limits institutional investor interest and results in very thin trading volumes in the unlisted market.
Low revenue relative to market cap (P/S ratio of 7.50) suggests revenue base is very small, raising concerns about business scale.
Diversified conglomerate structure across real estate, lifestyle, and healthcare with no apparent dominant segment may indicate lack of focused business strategy.
As an unlisted company with limited public disclosures, detailed financial performance and corporate governance details are difficult to assess.

Business Segments

Real Estate

Real estate assets, development, or investment activities.

Lifestyle

Lifestyle products or services segment.

Healthcare

Healthcare-related business activities.

Revenue Model

Revenue from real estate transactions, garment sales (SITARAA), wellness services, and dining revenue; diversified income streams across consumer segments.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds7

Growth Plans

Potential unlocking of real estate assets in New Delhi which has seen consistent property appreciation

Healthcare sector tailwinds in India post-pandemic could benefit the healthcare segment

Industry Tailwinds

Potential unlocking of real estate assets in New Delhi which has seen consistent property appreciation

Healthcare sector tailwinds in India post-pandemic could benefit the healthcare segment

Recent Developments

Revenue -49.56%, Profit -65.34% — significant performance decline

Dr Fresh Assets reported a significant deterioration in FY2023 with revenues down 49.56% and profits falling 65.34% vs. prior year. The company is working to stabilize its diversified portfolio operations.

FY2023

Comparable Companies

CompanyTypeTickerMkt Cap

Vedant Fashions (Manyavar)Listed ethnic fashion company — comparable to SITARAA brand in ethnic wear segment.Listed (NSE: MANYAVAR)——

Mahindra LifespacesListed real estate developer — comparable for real estate development vertical.Listed (NSE: MAHLIFE)——

Vedant Fashions (Manyavar)Listed (NSE: MANYAVAR)

Listed ethnic fashion company — comparable to SITARAA brand in ethnic wear segment.

Mahindra LifespacesListed (NSE: MAHLIFE)

Frequently Asked Questions

About Dr Fresh Assets

Dr Fresh Assets Limited (formerly 'Sunehari Exports Limited', renamed 17 May 2012) is a New Delhi-based diversified holding company incorporated on 6 December 1990. Listed on the Metropolitan Stock Exchange of India (MSEI), the company operates through a highly diversified portfolio of subsidiaries and divisions spanning real estate, healthcare, fashion/garments, Ayurvedic products, and luxury dining. The company's unusual portfolio breadth — unusual for a small-cap MSEI-listed entity — includes: (1) Dr. Fresh Commercial Land Development Pvt Ltd (real estate SPV), (2) Reverse Age Health Services Pvt Ltd (healthcare/wellness), (3) GSC Lifestyle Brands LLP (garments under the 'SITARAA' brand), and (4) a luxury dining brand 'TABLEMANNER.' It also operates an Export Oriented Unit at the Noida Export Processing Zone (NEPZ) for export activities. The company's financials showed deterioration in FY2023 — revenues declined 49.56% and profits fell 65.34% vs. the prior year. With authorized capital of ₹11 crore and paid-up capital of ₹10.82 crore, the company is small but maintains active operations across its diverse portfolio. For investors, Dr Fresh Assets represents an unusual conglomerate-in-miniature: a small MSEI-listed company attempting to build a diversified consumer portfolio. The revenue decline in FY2023 raises execution concerns, but the company's diverse business interests and active website presence suggest genuine operational activity across multiple verticals. The MSEI listing provides some regulatory oversight, though trading volumes on MSEI are typically very thin compared to BSE/NSE.

Key Milestones

Incorporated in 1990 in New Delhi, Delhi

Common questions about unlisted shares

How do I buy Dr Fresh Assets unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Dr Fresh Assets Limited

How settlement works

Get price alerts for Dr Fresh Assets Limited

Discuss Dr Fresh Assets

Similar companies

Other ways to invest